A Retrospective Analysis of Transfusion Management for Obstetric Hemorrhage in a Japanese Obstetric Center

Background. Since cryoprecipitate, fibrinogen concentrate, or recombinant activated factor VII is not approved by public medical insurance in Japan, we retrospectively assessed blood product usage in patients with obstetric hemorrhage at our tertiary obstetric center. Material and Methods. 220 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunaga, Shigetaka, Seki, Hiroyuki, Ono, Yoshihisa, Matsumura, Hideyoshi, Murayama, Yoshihiko, Takai, Yasushi, Saito, Masahiro, Takeda, Satoru, Maeda, Hiroo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302117/
https://www.ncbi.nlm.nih.gov/pubmed/22462007
http://dx.doi.org/10.5402/2012/854064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302117/
https://www.ncbi.nlm.nih.gov/pubmed/22462007
http://dx.doi.org/10.5402/2012/854064

Ejemplares similares